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                             INTRODUCTION 
 
Glaucoma is the second leading causes of blindness globally today.[1]  In 
India it is the third most common cause of blindness.[2] It is estimated that 
glaucoma affects 12 million in India and is responsible for 12.8% of the 
blindness in the country.[1] Glaucoma affects people of all ages producing serious 
health and economic consequences.[3] In nearly all cases blindness from 
glaucoma is preventable if the disease is detected early and proper treatment is 
implemented. 
 Primary open angle glaucoma is best defined as a chronic optic 
neuropathy with characteristic disc and field changes. The only therapeutically 
modifiable causal risk factor is intraocular pressure.[4] Overall, glaucoma can be 
classified based on the gonioscopic appearance of the angles, as open or closed 
angle glaucoma.[3] Glaucoma can also be classified as primary or secondary 
glaucoma.[3] In primary glaucoma, the disease exists without detectable 
contribution from other systemic or ocular disorders.[4] Secondary glaucoma is 
defined purely on the basis of raised intraocular pressure (IOP) with or without 
disc & field changes, associated with other ocular conditions known to contribute 
to IOP rise.[4] One such secondary open angle glaucoma is pseudoexfoliation 
glaucoma. 
Pseudoexfoliation is a generalized disorder and is commonly age-related, 
though often overlooked, and predisposes to a number of ocular complications, 
especially glaucoma.[5] It is presently acknowledged as the most common 
identifiable cause of secondary open angle glaucoma accounting for about 25% 
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of all open angle glaucomas worldwide.[6] This has also been shown in a study 
from south India where pseudoexfoliation was present in 26.7% of open angle 
glaucoma cases studied.[7] 
Pseudoexfoliation syndrome occurs in all geographic regions world wide 
with reported prevalence rates varying between 5% and 40% of the general 
population over the age of 60years.[6] In south India H. Arvind et al demonstrated 
a prevalence of 3.8% in those over 40 years of age.[8] In another study from south 
India, involving a similar age group, the prevalence of pseudoexfoliation was 
found to be 6.0%.[7]  
The etiology of pseudoexfoliation still remains unclear.[9] It is 
characterized as a disorder of extra cellular matrix associated with multifocal 
production of abnormal extra cellular fibrillar matrix, with the gradual 
accumulation of a specific fibrillar substance in virtually all tissues of the 
anterior segment of the eye, most importantly on the lens and pupillary 
margins.[5]  There is involvement of the lens, iris, ciliary body, trabecular 
meshwork and cornea and these changes in turn predispose to a spectrum of 
intraocular complications including chronic open angle glaucoma, angle closure 
glaucoma, lens subluxation or dislocation, pigment dispersion, poor mydriasis, 
posterior synechiae, blood-aqueous barrier defects and anterior chamber hypoxia, 
corneal endothelial decompensation and a significantly higher rate of intra- and 
post-operative complications in cataract surgery.[9] Recent evidence indicates that 
ocular features of pseudoexfoliation syndrome are actually only one facet of a 
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broader systemic process that involves skin and the connective tissue portion of 
various visceral organs.[9] 
Pseudoexfoliation associated secondary open angle glaucoma is called 
pseudoexfoliation glaucoma or exfoliation glaucoma or capsular glaucoma.[9] It 
develops in about half of patients with pseudoexfoliation syndrome over time.[1] 
Among glaucoma patients above the age of 50 years, the frequency of 
pseudoexfoliation syndrome is usually high and has been reported from 10-30% 
in the US, 50-60% in Northern Europe and 87% in Greece.[9] Raised intraocular 
pressure with or without glaucomatous damage occurs in 15-50% of 
pseudoexfoliation or about 6-10 times the rate in eyes without pseudoexfoliation  
syndrome.[6] In a similar age group studied in south India, raised intraocular 
pressure was seen in 16.7% of people with pseudoexfoliation and glaucomatous 
damage was present in 13%.[8]  In another study from south India, the reported 
prevalence of glaucoma in pseudoexfoliation was 7.5%.[7]    
The probability of eyes with pseudoexfoliation going on to develop 
glaucoma has been reported to vary from 5% to 33% within 5years and from 
15% to 40% within 10 years.[9]  In a prospective study over 10 years the progress 
from unilateral to bilateral pseudoexfoliation was 38%; the progress from 
unilateral to bilateral glaucoma was found to be 48% of patients with bilateral 
pseudoexfoliation syndrome within 15years.[10]  
Despite its clinical significance and many new insights in the recent 
years, pseudoexfoliation glaucoma is still underestimated and wrongly 
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diagnosed, leading to unexpected problems in clinical management and 
surgery.[9] 
There is universal agreement that compared to primary open angle 
glaucoma pseudoexfoliation glaucoma has a more serious clinical course and 
worse prognosis. It is typically associated with higher intraocular pressure levels, 
greater diurnal pressure fluctuations, marked pressure spikes, a higher frequency 
and severity of optic nerve damage, more rapid visual field loss, poorer response 
to medications and more frequent necessity for surgical intervention.[13, 14]  
Pseudoexfoliation glaucoma also differs from primary open angle glaucoma by a 
more frequent asymmetry of manifestation, more pronounced chamber angle 
pigmentation and acute pressure rise after mydriasis.[15] In contrast to patients 
with primary open angle glaucoma, patients with pseudoexfoliation glaucoma 
demonstrate a normal response to steroid application i.e. about one-third respond 
with a distinct pressure rise.[9] 
A significant correlation between the intraocular pressure levels at the 
time of diagnosis and the mean visual field defect could be established only in 
pseudoexfoliation glaucoma and not in primary open angle glaucoma patients,[15] 
suggesting intraocular pressure as the main risk factor for glaucomatous damage 
in this type of glaucoma.[16]  
These findings suggest that the glaucomatous damage in patients with 
pseudoexfoliation glaucoma may be more directly related to intraocular pressure 
than in primary open angle glaucoma, where the situation may be more 
complex.[17] The rapid progression of pseudoexfoliation glaucoma probably 
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reflects the cumulative effects of the daily trauma of intraocular pressure spikes 
on the optic nerve.[9] 
To date there are no established data concerning the necessity of testing 
diurnal variation of intraocular pressure in pseudoexfoliation. There is published 
literature on the effects of cataract surgery in eyes with pseudoexfoliation.  In 
this study we attempt to define the role of diurnal variation of intraocular 
pressure testing in the diagnosis of glaucoma in eyes with pseudoexfoliation, and 
also to find whether cataract surgery in pseudoexfoliation with normal 
intraocular pressure protects the eye from subsequent development of glaucoma.   
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                                                               AIMS 
 
 
1. To record the diurnal variation in intraocular pressure in eyes with 
pseudoexfoliation syndrome. 
2. To record the disc findings and visual fields in eyes with 
pseudoexfoliation syndrome. 
3. To determine the usefulness of diurnal measurement of intraocular 
pressure compared to initial intraocular pressure in diagnosing 
pseudoexfoliation glaucoma. 
4. To document the outcome of cataract surgery in patients with 
pseudoexfoliation in terms of intraocular pressure, disc appearance, visual 
improvement and field testing. 
5. To use the above data to determine, if possible, the effect of cataract 
surgery on intraocular pressure in pseudoexfoliation syndrome and 
pseudoexfoliation glaucoma. 
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REVIEW OF LITERATURE 
 
Glaucoma is currently the second leading causes of blindness in the 
world, after cataract.[1] In many developing countries, such as India, it is the third 
most common cause of blindness.[2] It is estimated that glaucoma affects 12 
million people in India and causes 12.8% of the blindness in the country.[1] As 
blindness due to glaucoma is irreversible, and it is seen in people of all ages, it is 
regarded as a significant public health and economic problem. Further, in nearly 
all cases, blindness from glaucoma is preventable if the disease is detected early 
and proper treatment is initiated and followed.[3] Detection of the disease depends 
on educating the general public regarding the importance of routine eye 
examinations and training fellow health professionals to recognize the signs and 
symptoms of glaucoma.[3]  
Primary open angle glaucoma can be defined as a chronic optic 
neuropathy which has characteristic disc and field changes. The only 
therapeutically modifiable causal risk factor is intraocular pressure.[4] Glaucoma 
is a multifactorial disease; elevated intraocular pressure remains an important 
risk factor and intraocular pressure reduction is still the only treatment of proven 
benefit.[5]  “Normal” intraocular pressure may be defined for the individual eye as 
that pressure which is sufficient to maintain the structural relationships of ocular 
anatomy without producing glaucomatous nerve damage.[4] The normal range of  
intraocular pressure in the general population is generally accepted to be 10-21 
mmHg.[3] There are many factors that can affect intraocular pressure such as age, 
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sex and race. Hereditary and seasonal variation, cardiovascular factors, exercise, 
postural changes, neural factors, hormonal factors, refractive error, eye 
movements, inflammation and surgery can all affect IOP.  Most importantly, IOP 
is not a static value but goes through a variation in level throughout the day in 
normal and diseased eyes.[3]  
Over the course of the day, the intraocular pressure varies an average of 
3-6 mmHg in normal individuals.[3, 4] Patients with glaucoma have much wider 
swings. It has been found the intraocular pressure is generally found to be high in 
the mornings and minimum at late night or early morning. Some people peak in 
the afternoon or in the evenings.[9]  Most of the variation in intraocular pressure 
that occurs during the diurnal cycle is attributable to changes in the rate of 
aqueous humor production.[18] This variation in pressure according to some 
investigators is in response to circulating catecholamine. The diurnal variation in 
intraocular pressure follows the diurnal glucocorticoid cycle, with intraocular 
pressure peaking about 3-4 hrs after plasma cortisol.[3]  
The concept of “target pressure” or an individually tailored intraocular 
pressure at which, for a given patient, significant visual loss is avoided allied 
with evidence that a 30% reduction in intraocular pressure limits visual field loss 
in normal tension glaucoma only serves to reaffirm the measurement of 
intraocular pressure as central to the management of glaucoma patients.[19]  
Despite this, diagnostic and management decisions are frequently made 
after single or infrequent intraocular pressure measurements at varying times of 
the day.[20]  Measurement error and diurnal intraocular pressure fluctuation may 
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contribute to an under-estimation of peak intraocular pressure with consequent 
over diagnosis of normal tension glaucoma or an incorrect belief that “target 
pressure” has been attained.[21]  These concerns led to the development of diurnal 
measurement of intraocular pressure. This could be carried out as 24 hr 
monitoring of intraocular pressure or clinic (office) based monitoring of 
intraocular pressure.[22] Edward Hughes and co-workers demonstrated that 24 hr 
monitoring of intraocular pressure was better than single IOP recording in 
management decisions in glaucoma.[20]  
Pseudoexfoliation was described by the Finnish ophthalmologist 
Lindberg.[5] Vogt emphasized the association with glaucoma and, in fact, called it 
glaucoma capsulare; Sampaolesi elaborated on melanin dispersion and changes 
in the blood-aqueous barrier in PEX; Tarkanen focused on the involvement of 
ciliary processes; Ringvold showed pseudoexfoliation in the conjunctiva; Garner 
et al showed pseudoexfoliation on the zonules and Schlötzer et al showed 
systemic involvement.[5,9]  
The pseudoexfoliation syndrome is characterized by formation and/or 
deposition of a fibrillo-granular material throughout the anterior segment, and is 
often accompanied by raised intraocular pressure with or without glaucomatous 
optic nerve and visual field damage.[23] Although glaucoma in pseudoexfoliation 
has many similarities to primary open angle glaucoma, the pathogenetic 
mechanism of the two diseases may be quite different.[9] Glaucoma is more 
prevalent and its prognosis more severe in eyes with pseudoexfoliation than in 
those without pseudoexfoliation.[24-28] There is no known sex predilection for 
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pseudoexfoliation, but study by Randy A Karger et al found that women are 
more predisposed to developing pseudoexfoliation. Hormonal factors were cited 
to be the cause of this predilection.[29]  
Pseudoexfoliation syndrome occurs in all geographic regions world-wide 
with reported prevalence rates varying between 5% and 40% of the general 
population over the age of 60yrs.[6] In south India, in a study done by H Arvind et 
al, patients equal to or above the age of 40yrs were studied. The prevalence of 
pseudoexfoliation syndrome in this population was 3.8%.[8] In another study 
from south India, studying similar age group, the prevalence of pseudoexfoliation 
was found to be 6.0%.[7]  
For unknown reasons, patients can present with unilateral or bilateral 
involvement, which can be markedly asymmetrically. Unilateral involvement is 
often regarded as a precursor to bilateral involvement.[30]  Pseudoexfoliation 
syndrome manifests unilaterally in about 50-70% of patients and the conversion 
rates from clinically unilateral to bilateral disease were found to vary from 15-
40% within 5yrs.[31]  
Unilateral pseudoexfoliation syndrome occurs at a younger age than 
bilateral disease, mostly as a consequence of prior intraocular surgery or trauma 
to the anterior segment, particularly to the iris, which may serve as a trigger for 
the premature development of pseudoexfoliation in a predisposed individual.[9]  
Puska et al did not find any prognostic factors for conversion of unilateral to 
bilateral exfoliation.[10]  
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Pseudoexfoliation syndrome is diagnosed on visualization of 
pseudoexfoliation material on the anterior lens capsule and/or pupillary margin. 
There are also less commonly appreciated signs related to loss and dispersion of 
pigment from the iris pigment epithelium.[32] These include loss of pupillary ruff, 
pigment deposition on the iris sphincter region, iris transillumination defects, 
anterior chamber pigment dispersion after pupillary dilation and moderate or 
dense pigmentation of the trabecular meshwork.[33-36] 
Exfoliation material may be detected earliest on the ciliary processes and 
zonules. However, the majority of intraocular pseudoexfoliation deposits cannot 
be observed by direct biomicroscopy, and the accumulations on zonules, ciliary 
processes, and trabecular meshwork may only be detected on gonioscopy or 
cycloscopy or may be visualized by high resolution ultrasound biomicroscopy.[37]  
Scattered flakes of pseudoexfoliation have been observed on the 
endothelium. Pigment deposition usually causes a diffuse, nonspecific 
pigmentation of the central endothelium, occasionally having the pattern of  
Krukenberg’s spindle.[6] More frequently, one or more undulating pigmented 
lines can be observed in the peripheral cornea anterior to Schwalbe’s line. 
Specular microscopy demonstrates a reduced endothelial cell density, even with 
normal intraocular pressure.[9]  
Exfoliation material can also be produced by corneal endothelial cells.[38] 
In the affected areas, the endothelial layer appears irregular and discontinuous 
with detaching and degenerating endothelial cells. Subsequent re-
endothelialization of denuded areas of Descemet’s membrane by neighboring 
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fibroblastic endothelial cells leads to incorporation of pseudoexfoliation material, 
cellular debris and pigment granules into Descemet’s membrane.[6]  Naumann et 
al have suggested that a true keratopathy, distinct from Fuch’s dystrophy and 
pseudophakic bullous keratopathy, can be found in eyes with pseudoexfoliation 
and this predisposes them to early corneal endothelial decompensation with only 
moderate elevations of intraocular pressure or following cataract surgery.[5]  
Regardless of whether the zonules are coated with pseudoexfoliation 
material or are actually replaced by it, they are often frayed and broken. 
Abnormal zonular attachments to the lens or ciliary body may account for the 
development of lens subluxation or dislocation.[9] Deposits of pseudoexfoliation 
material cover the crests of the ciliary processes in the pars plicata, whereas the 
posterior ciliary body or pars plana is generally devoid of it.[6]  
The clinically observed instability of the zonules may be explained by 
alterations of the zonular fibers themselves and their impaired anchorage in the 
defective basement membranes of the ciliary body and lens.[39] At their origin 
and anchorage in the ciliary body, the zonular bundles are separated from the 
disrupted basement membrane of the non-pigmented epithelium by locally 
produced exfoliation material. The zonular bundles passing alongside the ciliary 
processes are focally infiltrated by exfoliation material. At their attachment to the 
anterior lens capsule, the zonular lamellae is focally lifted off and ruptured by 
masses of exfoliation material erupting through the capsular surface.[6] 
For a clinical diagnosis of pseudoexfoliation the most important 
diagnostic criteria are whitish flake-like deposits of pseudoexfoliation material 
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on anterior segment structures, particularly on the anterior lens surface and the 
pupillary margin, occasionally also on the posterior surface of the cornea, on the 
anterior surface of intraocular lens implants, and on the anterior vitreous face in 
aphakic eyes.[9]  
In early stages of pseudoexfoliation, it has been shown by electron 
microscopy that a diffuse-matte homogenous film on the surface of the anterior 
lens capsule consist of a layer of micro fibrils, a precursor of pseudoexfoliation 
fibrils, deposited from the aqueous humor.[20, 40] As the precapsular layer 
becomes thicker, focal defects begin to form here by abrasive movements of the 
iris, often in the upper nasal quadrant, which further enlarge and become 
confluent to form the classical picture of manifest pseudoexfoliation syndrome.[9]  
The characteristic target-shaped pattern on the lens, consisting of a rather 
homogenous central disc, an intermediate clear zone, and a peripheral granular 
zone, can be only seen after pupillary dilation.[8] In routine examinations without 
pupillary dilation, the diagnosis may be easily missed, because the central disc 
may be very subtle or even absent in 20-50% of cases.[9] The central disc, 
corresponding to the size of the pupil, appears to result from diffuse 
sedimentation of pseudoexfoliation material from the aqueous, whereas the 
peripheral granular zone builds up undisturbed accumulation of nodular 
pseudoexfoliation aggregates produced by iris pigment epithelium; the 
intermediate clear zone is created by abrasive movements of the peripupillary iris 
during pupillary movement.[20]  
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Variations of this general pattern include; the lack of a central disc, 
bridges of pseudoexfoliation material crossing the intermediate clear zone, and a 
layered or striated peripheral granular zone with or without curled edges.[9] In the 
clinically invisible pre-equatorial region of the lens, pseudoexfoliation aggregates 
appear to be locally produced by the metabolically active pre-equatorial lens 
epithelium, to penetrate the lens capsule and loosen the attachment of the zonular 
fibers to the anterior lens capsule, giving rise to a pronounced zonular weakness 
in pseudoexfoliation eyes.[5] 
Several other clinical signs aid in the diagnosis.[5, 31] Exfoliative material 
is often prominent at the pupillary border. Pigment loss from the peripupillary 
iris pigment epithelium and its deposition on anterior chamber structures is a 
hallmark of pseudoexfoliation syndrome.[6]  Pigment dispersion is caused by 
rubbing of the peripupillary iris against the rough anterior lens surface during 
pupillary movement and rupture of the degenerative iris pigment epithelial cells 
with liberation of melanin granules. This manifests clinically in a peripupillary 
atrophy producing a characteristic “moth eaten” transillumination pattern, 
pupillary ruff defects, pigment dispersion after pupillary dilation and deposition 
of melanin granules on the iris surface, the corneal endothelium and the 
trabecular meshwork.[9] These signs can precede the clinical appearance of 
pseudoexfoliation material on the lens surface. Patients with absence of clinically 
identifiable exfoliative material on the anterior lens capsule or pupillary   
margin are called “exfoliation suspects”.[30]      
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Exfoliation material accumulates within the stromal connective tissue and 
the anterior border layer, and in the walls of stromal blood vessels. The vessel 
lumens are often narrowed and may become obliterated, with marked alteration 
of iris vasculature in advanced cases. Vessel dropout with collateral formation 
and iris hypoperfusion lead to patchy iris microneovascularisation and diffuse, 
patchy fluorescein leakage, especially in the pupillary region.[9] In advanced 
stages, the vascular wall cells degenerate completely. Degenerative changes of 
sphincter and dilator muscle tissues and apparent involvement of the muscle cells 
in exfoliation fiber formation have been described and may contribute to poor 
pupillary dilation.[41] 
Increased trabecular meshwork pigmentation, particularly in the inferior 
half, is a prominent sign of pseudoexfoliation syndrome.[9] Unlike pigment 
dispersion syndrome, the distribution of the pigment tends to be uneven or patchy 
and less well defined. Pigment is also characteristically deposited on or anterior 
to Schwalbe’s line (Sampolesi’s line).[6] Exfoliation material can be found in the 
trabecular spaces, within the trabecular beams, and in the periphery of 
Schlemm’s canal. Most deposits are found in the juxtacanalicular tissue beneath 
the inner wall of Schlemm’s canal and in the uveal meshwork, whereas the 
corneoscleral portion of the meshwork appears to be largely uninvolved.[32] 
In the juxtacanalicular tissue, pseudoexfoliation material has been found 
within vacuole-like spaces and surface invaginations of the endothelial cells, 
suggesting local production by endothelial cells that line Schlemm’s canal.[9] In 
eyes with advanced exfoliative glaucoma, masses of pseudoexfoliative material 
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accumulate along the whole periphery of Schlemm’s canal, causing considerable 
disorganization of the normal tissue architecture.[6]  
Pseudoexfoliative material may be found on the vitreous face, on vitreous 
strands when the face is ruptured, on the posterior capsule and on intraocular 
lenses, indicating that the presence of the lens is unnecessary for its continued 
formation.[6] Pseudoexfoliation associated signs that alert the clinician to the 
presence of pseudoexfoliation include phacodonesis, iris stroma atrophy, iris 
hemorrhages after pupillary dilation, increased aqueous flare values, elevated 
intraocular pressure and insufficient pupillary dilation, particularly if 
asymmetrically present.[9]     
In an ultra structural study done by T.Hammer etal,[30] it was found that 
clinically unilateral pseudoexfoliation has sub clinical alteration of the contra 
lateral noninvolved eyes. These included 1) deposits of typical pseudoexfoliation 
fibrils on the iris and ciliary epithelia and in the dilator muscle of the iris,  
2) increased accumulation of extracellular matrix, including micro fibrils and 
reduplicated basement membrane material in the periphery of iris vessels, in the 
dilator muscle and in the juxtacanalicular tissue of trabecular meshwork, 
3) degenerative changes of iris pigment epithelium and dilator muscle cells.[42]     
The etiology of pseudoexfoliation remains unclear.[9] The characteristic 
fibrils, which are composed of microfibrillar units resembling elastic micro 
fibrils contain epitopes of elastic fibers.[5] They appear to be multifocally 
produced by various extra and intraocular cell types, including the pre-equatorial 
lens epithelium, non-pigmented ciliary epithelium, trabecular endothelium, 
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corneal endothelium, vascular endothelium and virtually all cell types in iris, by 
active fibrillogenesis.[6] This fibrillogenesis is accompanied by a destruction of 
the normal extra cellular matrix of cells, normally represented by their basement 
membrane and is followed by a degeneration of cells involved due to a disturbed 
cell-matrix interaction ( degenerative fibrillopathy).[9] 
Excessive matrix accumulates may be due to increased denovo synthesis 
or a decreased turnover of matrix components or both and may be influenced by 
growth factors, proteolytic enzymes and their inhibitors and free radicals.[9] 
Biochemical analyses showed significantly increased concentration of the 
transforming growth factors (TGF-ß) both in its latent and active form, in the 
aqueous humor of pseudoexfoliation patients with or without glaucoma 
compared to age-matched controls with cataract or primary open angle 
glaucoma.[42] This growth factor has been known as a powerful modulator of 
matrix formation in many fibrotic diseases. 
There has been an increasing awareness of growth factors in aqueous 
humor homeostasis, leading to development of raised intraocular pressure and 
glaucoma.[43, 44] As the aqueous humor bathes the anterior segment its compounds 
affect the metabolic functioning of cells lining the conventional outflow routes, 
that is, the trabecular meshwork. In humans, the trabecular meshwork is made up 
of collagen beams covered by endothelial like cells.[45] The space between the 
beams are filled with extracellular matrix. The extracellular matrix in the 
subendothelial region of Schlemm’s canal plays an important part in the 
pathogenesis of glaucoma.[46] Elevated intraocular pressure may be attributed to 
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abnormal deposition of extracellular matrix resulting in a reduced filtration 
capacity.[47, 48]  
There are several mechanisms by which presence of certain growth 
factors are seen in aqueous humor. These include selective ultra filtration of low 
molecular weight growth factors from serum, local intraocular synthesis and 
release of growth factors, diffusional exchange of growth factors between 
aqueous and vitreous humor and selective transport system for certain growth 
factors.[44] The blood-aqueous barrier contributes partial control on the types and 
levels of growth factors that enter the aqueous humor in health and diseases.[45]  
 Other factors like basic fibroblast growth factor (bFGF)[48] and 
hepatocyte growth factor (HGF)[49] and 8-isoprostaglandin F2α[50] in the aqueous 
humor. It has been speculated that these findings are indicative of oxidative stress 
as well as an abnormality in fibrogenesis, matrix degradation and cellular 
response to injury in the anterior segment of pseudoexfoliation eyes.[45] 
TGFß1, a fibrogenic cytokine, has a pivotal role in the ocular wound 
healing process. It is also essential in maintenance of anterior chamber associated 
immune derivation.[44] It promotes deposition of extracellular matrix by down 
regulating the production of proteases and stimulating the synthesis of protease 
inhibitor.[45]  
Connective tissue growth factor (CTGF) also plays a part in extracellular 
matrix deposition remodeling and wound healing by promoting collagen 
synthesis and regulating the expression of matrix metalloproteinases (MMP) and 
tissue inhibitors of matrix metalloproteinases (TIMP).[45] It has been shown by 
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Van Satten et al that connective tissue growth factor levels are higher in aqueous 
humor of pseudoexfoliation glaucoma patient, suggesting involvement of CTGF 
in fibrotic pathology of pseudoexfoliation syndrome and its association with 
glaucoma. The high levels of CTGF has been demonstrated by western blot 
analysis and ELISA.[51]   
Aqueous humor from pseudoexfoliation patients also had higher levels of 
matrix metalloproteinases (MMP-2 and MMP-3) as well as their inhibitors 
TIMP-1 and TIMP-2 as compared to controls.[52] However, levels of 
endogenously active MMP-2, which is the major matrix metalloproteinases in 
human aqueous humor, were significantly decreased as was the ratio of MMP-2 
to TIMP-2. These findings suggest that an excess of TIMP-2 over MMP-2 and a 
reduced MMP-2 activity in the eyes of pseudoexfoliation patients may promote 
the abnormal matrix accumulation due to impaired matrix turnover. TIMP’s also 
bind pseudoexfoliation  material creating so-called cold spots for proteolysis.[9]  
Significantly reduced levels of ascorbic acid, an important free radical 
scavenger in the eye and concomitantly increased levels of 8-isoprostaglandin 
F2α, marker of oxidative stress have further been reported in aqueous humor of 
pseudoexfoliation patients, suggesting a faulty antioxidative defense system and 
increased oxidative stress in the pathogenesis of pseudoexfoliation syndrome.[9]  
The presence of glycoaminoglycans has also been shown by application 
of the sulphate- binding dye cuprolinic blue and by immune histochemical 
evidence for the presence of heparin sulphate proteoglycan, chondroitin sulphate 
proteoglycan, dermatan sulphate proteoglycan and hyaluronan. It has been 
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suggested that the HNK-1 epitope, a carbohydrate moiety present on many cell 
adhesiveness of pseudoexfoliative material deposits on intraocular surfaces.[53] 
Among glaucoma patients above the age of 50yrs, the frequency of 
pseudoexfoliation syndrome is usually high and has been reported from 10-30% 
in US, 50-60% in Northern Europe and 87% in Greece.[9] Raised intraocular 
pressure with or without glaucomatous damage occurs in 15-50% of 
pseudoexfoliation or about 6-10 times the rate in eye without pseudoexfoliation 
syndrome. In a similar age group studied in south India, raised intraocular 
pressure was seen in 16.7% of people with pseudoexfoliation and glaucomatous 
damage was present in 13%.[8]  In another study from  south India, the reported 
prevalence of glaucoma in pseudoexfoliation was 7.5%.[7] 
The probability of pseudoexfoliation eyes to develop glaucoma has been 
reported to vary from 5% to 33% within 5yrs and from 15% to 40% within 10yrs; 
the progress from unilateral to bilateral glaucoma was found to be 48% of 
patients with bilateral pseudoexfoliation syndrome within 15yrs.[9] In a recent 
study involving patients with clinically unilateral pseudoexfoliation syndrome, 
conversion to pseudoexfoliation glaucoma was 38% in the initially non-involved 
fellow eyes with in 10yrs, suggesting that glaucoma may develop before there are 
any clinical signs of pseudoexfoliation material.[31] In a study done by P Puska et 
al factors that were associated with conversion to exfoliation glaucoma were 
initial intraocular pressure, pupillary dilation value and the intraocular pressure 
difference between the fellow eyes.[10] 
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Compared to primary open angle glaucoma, pseudoexfoliation glaucoma 
has a more serious clinical course and worse prognosis.  It is typically associated 
with higher intraocular pressure levels, greater diurnal pressure fluctuations, 
marked pressure spikes, a higher frequency and severity of optic nerve damage 
and more rapid visual field loss, a poorer response to medications and a greater 
necessity for surgical intervention.[13, 14] 
Pseudoexfoliation glaucoma differs from primary open angle glaucoma 
by a more frequent asymmetry of manifestation, more pronounced chamber angle 
pigmentation and acute pressure rise after mydriasis. In contrast to patients with 
primary open angle glaucoma, patients with pseudoexfoliation glaucoma behave 
like normal persons after steroid application i.e. only one third responds with a 
distinct pressure rise.[54]  
The percentage area of optic disc pallor was shown to be significantly 
greater in eyes with pseudoexfoliation than in control eyes and the mean disc 
area has been reported to be significantly smaller in eyes with pseudoexfoliation, 
with or without glaucoma than in primary open angle glaucoma eyes and control 
normal eyes.[11] There were, however, no significant differences in neuroretinal 
rim area, area of peripupillary atrophy, rim disk ratio, cup area and cup volume 
between pseudoexfoliation eyes and control or primary open angle eyes.[11, 12]The 
occurrence of a small optic disc in eyes with pseudoexfoliation glaucoma is 
diagnostically important, because in a small optic disc glaucomatous damage 
may be missed and the discs may  erroneously be considered normal.[9] 
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The lamina cribrosa of the optic disc appears to undergo elastosis, 
although pseudoexfoliation material has not been identified in this region.[9] 
Netland et al demonstrated a marked and site specific elastosis of the lamina 
cribrosa, which is more pronounced in eyes with pseudoexfoliation glaucoma 
than in primary open angle glaucoma, suggesting an abnormal regulation of 
elastin synthesis and or degradation. These alterations of the connective tissue at 
the level of the lamina cribrosa may increase the susceptibility of optic nerve 
fibers towards mechanical and ischemic damage.[55] 
The mechanical component of optic nerve damage certainly predominates 
but the risk of further glaucomatous damage is increased by vascular factors and 
pseudoexfoliation associated alteration of blood vessels.[9] Many studies have 
reported general disturbance of ocular and retro bulbar perfusion in 
pseudoexfoliation patients with or without glaucoma.[9] It has been shown a 
pronounced vasculopathy of the iris with hypoperfusion and anterior chamber 
hypoxia, a reduction of pulsatile ocular blood flow and a significantly diminished 
blood flow velocities and increased resistivity indices in the ophthalmic artery, 
the central retinal artery and short posterior ciliary arteries.[56] 
Higher rates of disc hemorrhages and central retinal vein occlusions have 
been reported in pseudoexfoliation glaucoma patients.[57] It has also been shown 
that retinal vessel caliber did not differ between pseudoexfoliation glaucoma and 
primary open angle glaucoma.[11] Morphological correlates of these 
pathophysiologic findings are perivascular accumulations of pseudoexfoliation 
material and elastotic alterations of vessel walls, as they have been demonstrated 
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by electron microscopy in the walls of iris vessels, aqueous veins , ciliary arteries 
and central retinal artery.[5, 58]  
A significant correlation between the intraocular pressure level at the time 
of diagnosis and the mean visual field defect could be only established in 
pseudoexfoliation glaucoma but not in primary open angle glaucoma patients, 
suggesting intraocular pressure as the main risk factor for glaucomatous damage 
in this type of glaucoma.[15] In a study by Anastasios G et al it was found that the 
visual field defect in eyes with pseudoexfoliation was worse than in eyes  with 
primary open  angle glaucoma.[54] 
These findings suggest that the glaucomatous damage in patients with 
pseudoexfoliation glaucoma may be more directly related to intraocular pressure 
than in primary open angle glaucoma, where the situation may be more complex. 
The rapid progression of pseudoexfoliation glaucoma probably reflects the 
cumulative effects of the daily trauma of intraocular pressure spikes on the optic 
nerve.[9] 
It is presumed that increase in intraocular pressure in patients with 
pseudoexfoliation syndrome is secondary to increased outflow resistance that 
results from mechanical blockage of the trabecular meshwork by pigment and 
exfoliative material.[59] In a study done by Johnson and Brubaker[60] ,aqueous 
flow was decreased by 20% in the affected eyes. In a study by Lutjein et al it has 
been noted that ultrastructural changes in ciliary epithelium of eyes with 
exfoliation glaucoma that indicated increase protein synthesis and decreased 
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active transport in these cells and thereby increase resistance to outflow of 
aqueous.[59] 
Histopathological analyses indicated fundamental differences in nature of 
pseudoexfoliation glaucoma and primary open angle glaucoma. Primary open 
angle glaucoma is characterized by increased juxtacanalicular plaque material 
and decreased trabecular meshwork cellularity whereas both plaque material and 
cellularity are unchanged in pseudoexfoliation glaucoma compared to normal 
eyes, but there is production and deposition of the characteristic fibrillar 
pseudoexfoliation material.[61] 
Thus the primary cause of chronic pressure elevation in pseudoexfoliation 
eyes appears to be active participation of trabecular endothelial cells, particularly 
Schlemm’s canal endothelial cells, in the generalized abnormal matrix process, 
leading to local production and accumulation of pseudoexfoliation material in the 
juxtacanalicular region of the meshwork and subsequent degenerative alteration  
of Schlemm’s canal wall.[62] A partial mechanism may be that a 
pseudoexfoliation clump could be passively washed in with aqueous flow after 
abrasion from the lens and pupillary margin and may be trapped in the uveal 
pores of the meshwork.[29]  
Even though it is most widely held that obstruction of trabecular pores by 
pseudoexfoliation material, either locally produced or passively deposited, is 
major mechanism of chronic pressure elevation, contributions due to pigment 
dispersion and increased aqueous protein concentrations have been proposed.[61] 
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Another interesting observation has been the proliferation of corneal 
endothelial cells beyond Schwalbe’s line resulting in pretrabecular layer of 
extracellular material including pseudoexfoliation fibrils produced by migrating 
or proliferating endothelial cells.[58, 61] This may be a consequence of anterior 
chamber hypoxia in pseudoexfoliation eyes, stimulating corneal endothelial cell 
proliferation. Such observation may partially explain why there is a variable 
response to medical therapy with some patients seeming to respond so poorly.[9] 
Another point of view of increased intraocular pressure is that 
pseudoexfoliation is associated with angle closure or narrow angles. In a study by 
Layden and Shaffer[63] 23% of their cases with exfoliation syndrome had narrow 
angles . Ritch [64] found signs of pseudoexfoliation in 28% of consecutive 
patients with angle closure glaucoma. Eyes with pseudoexfoliation have  often 
narrowed chamber angle[59, 65] and smaller anterior chamber volumes and in the 
presence of weak zonules, a minimal anterior subluxation of the lens predisposes 
to development of angle closure glaucoma via pupillary  block.[65] The decrease 
in anterior chamber depth between the supine and prone position was shown to 
be greater in eyes with pseudoexfoliation.[66] 
Characteristic features of pseudoexfoliation eyes that may predispose to 
the development of pupillary block angle-closure glaucoma include the formation 
of posterior synechiae, an increased iris rigidity and decreased iris motility, an 
impairment of blood-aqueous barrier and increased protein concentrations of 
aqueous humor and anterior  movement of the lens secondary to zonular 
weakness.[5] In extreme and rather rare cases with marked zonular laxity, anterior 
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displacement of the lens may be so pronounced that a ciliary block angle-closure 
glaucoma is induced by contraction of ciliary muscle.[67]  
It was found that pseudoexfoliation patients with narrow or occludable 
angles were hyperopic, which suggests that axial length and anterior chamber 
related to the increased prevalence of occludable angles and angle-closure 
glaucoma in pseudoexfoliation.[65]    
Miotics may aggravate both pupillary block and forward movement of the 
lens-iris diaphragm. A narrow angle associated with pseudoexfoliation syndrome 
may therefore, represent an additional argument for prophylactic iridotomy.[68] 
Secondary angle-closure glaucoma following central retinal vein occlusion with 
rubeosis iridis may also occur in pseudoexfoliation eyes, because retinal vein 
occlusion appears to be more common in patients with pseudoexfoliation 
syndrome or glaucoma, perhaps due to high intraocular pressure values.[57]    
The differential diagnoses of pseudoexfoliation syndrome are: pigment 
dispersion syndrome or pigmentary glaucoma, Fuch’s heterochromic 
iridocyclitis, uveitis, diabetes mellitus etc. Retro corneal pseudoexfoliation 
accumulations may be misdiagnosed as inflammatory precipitates.[9] In pigment 
dispersion syndrome or glaucoma, the trabecular meshwork pigmentation is 
dense and even compared to the irregular patchy pigmentation in 
pseudoexfoliation syndrome or glaucoma. The iris transillumination defects of 
pigment dispersion syndrome or glaucoma appear as mid peripheral radial 
spokes, whereas those in pseudoexfoliation appear as moth eaten patches around 
the pupil.[69] 
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In a study done in south India, to study the profile of pseudoexfoliation in 
Indian population, it was found that the mean age of subjects with 
pseudoexfoliation syndrome is 11.16 years older than normal population studied 
(≥40yrs).There was no sex predilection and the mean intraocular pressure was 
1.29mmhg higher than normal population. Ocular hypertensives were 9.3% and 
with glaucomatous optic neuropathy were 13% of pseudoexfoliation cases. The 
prevalence of narrow angles with pseudoexfoliation was 14.8%, which is twice 
the prevalence without pseudoexfoliation. It was found that nuclear sclerosis was 
more prevalent in eyes with pseudoexfoliation.[8] 
Goldmann applanation tonometry is the clinical standard for 
measurement of intraocular pressure. It determines the force necessary to flatten 
or applanate an area of the cornea 3.06mm in diameter. For this area of 
applanation, the intraocular pressure in millimeters of mercury is equal to the 
force of the tonometer in grams multiplied by 10. Applanation tonometry 
displaces only 0.5µl of aqueous humor. Goldmann tonometry is quite accurate 
and reproducible if proper technique is used. Inter-observer variability is in the 
range of 0 to 3mmhg which is less than the diurnal variation of intraocular 
pressure. The tear meniscus is stained with fluorescein dye, and when viewed in 
blue light, the fluorescence of the dye-stained meniscus is easily distinguishable 
from the flattened area of cornea beneath the instrument’s contact surface. The 
examiner uses a slit lamp biomicroscope to view the surface of the applanated 
cornea through the centre of the prism.[18]  
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An interesting and unanswered question is why some eyes with 
pseudoexfoliation appear to never develop glaucoma.[70] This may be explained 
simply by the individual amount of pseudoexfoliation material present in the 
outflow structures, by inter-individual differences in managing the metabolic 
disturbances, by additionally required predisposing or genetic factors, or by inter-
individual differences in the susceptibility to optic nerve damage, mediated by 
vascular or structural factors.[9] An underlying defect in aqueous humor dynamics 
or involvement of glaucoma susceptibility gene may also be considered as a 
requirement for glaucoma development in pseudoexfoliation eyes, because 
patients with unilateral pseudoexfoliation syndrome may also have glaucoma in 
the fellow eye.[10] Degeneration of ciliary epithelium is part of the disease, and 
reduced aqueous secretion may explain why some eye with pseudoexfoliation do 
not develop glaucoma.[9]     
There are few published studies on the effects of cataract surgery on  
pseudoexfoliation glaucoma.[71] It is reported that though cataract surgery does 
not eliminate post operative intraocular pressure elevations, it reduces their 
frequency and magnitude. But the exact mechanism is not well understood.[72] 
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MATERIALS AND METHODS 
 
 
This study was conducted in the Department of Ophthalmology, Christian 
Medical College from March 2005 to June 2006. 
TYPE OF STUDY: 
Prospective cohort study 
INCLUSION CRITERIA: 
All patients found to have pseudoexfoliation in one or both eyes on presentation, 
with or without evidence of glaucoma. 
EXCLUSION CRITERIA: 
Patients were excluded from the study if any one or more of the following was 
present: 
1. Any patient who had previously undergone any intraocular surgery in the 
eye with pseudoexfoliation. 
2. Any patients on anti-glaucoma medications or on topical or systemic 
steroids. 
3. Any patient with a history of ocular trauma or a documented history of 
uveitis. 
4. Any other ocular pathology apart from age-related cataract that could 
contribute to development of a secondary glaucoma, eg corneal scars 
suggestive of suppurative keratitis. 
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METHODS: 
All patients presenting in the OPD were screened for pseudoexfoliation as part of 
the routine ocular examination. Those who had pseudoexfoliation material on the 
corneal endothelium, the pupillary margin, the angle or on the lens were recruited 
for the study.  Consent for participation in the study was obtained.  DVT was 
recorded, and details of the clinical examination necessary for the study were 
confirmed and then entered in the proforma (see Appendix I).  These included 
gonioscopy findings, grade of cataract, presenting IOP and dilated pupil disc 
appearance.  Depending on the best corrected visual acuity, visual field 
assessment by Humphrey’s Field Analyzer II was attempted. 
Test for diurnal variation of intraocular pressures in all patients was done 
by a single observer. The diurnal variation of intraocular pressure was taken 
between 9:30am and 3:30pm at 2 hourly intervals. The IOP was recorded using 
Goldmann’s applanation tonometer on a Zeiss slit lamp biomicroscope. 
Calibration of the tonometer was checked weekly as part of the routine 
maintenance protocol of the department. The same instrument was used for all 
recordings.  Patients enrolled in this study who were undergoing cataract surgery 
had their diurnal variation of intraocular pressure and visual field assessment by 
Humphrey’s Field Analyzer II repeated 6 weeks after surgery. Those not 
undergoing a surgical procedure were followed up every 3 months for assessment 
of DVT and visual field assessment.    
Cataract surgery was performed according to existing department 
protocols.  The surgical techniques used included Blumenthal manual sutureless 
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small incision cataract surgery, sutureless phacoemulsification and standard 
extracapsular cataract surgery with 10-0 sutures.  An intraocular lens was 
routinely implanted; these were usually single piece PMMA posterior chamber 
lenses.  Anterior chamber or sclerally fixated lenses were used as indicated.  No 
effort was made to control or direct the type of surgery for study patients.  The 
treatment decisions were made by personnel not involved with the study based 
entirely on the merits of the individual case. 
Patients found to have PEX glaucoma were offered combined glaucoma 
and cataract surgery in accordance with the preferred practice pattern of the 
department.  It had been debated within the department whether it was 
worthwhile attempting medical control of IOP followed by cataract surgery with 
subsequent withdrawal of medication to assess the effect that cataract surgery 
had on IOP in PEX glaucoma.  However, because of the serious nature of the 
condition, its rapid progression and compliance and follow up problems, it was 
felt that it was ethically indefensible to deviate from established protocol for 
patients with IOP ≥ 30mmHg or with advanced disc changes.  It was considered 
permissible to offer an option of medical treatment when IOP was <30mmHg 
with minimal or no disc damage. As the primary aim of the study was to 
determine whether DVT assisted the diagnosis of PEX glaucoma, our main 
concern was with patients presenting with initially normal IOP to see if DVT 
revealed any reading outside the normal range. PEX glaucoma was defined by 
the presence of intraocular pressure >21mmHg in an eye with PEX in accordance 
with accepted definitions of a secondary glaucoma. 
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SAMPLE SIZE: 
Sample Size was calculated by the formula: 
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where, θ0 = sample reliability = 0.4 
θ1 = population reliability = 40% 
K= number of replications = 1(in this study) 
 
By the above formula, the sample size calculated is 80.  We chose to include 100 
patients to allow for failure in follow up and dropouts.  
 
STATISTICAL METHODS: 
 
Intra Class Correlation Coefficient Ratio: Intraclass correlations (ICC) are often 
used as measures of agreement for items that are deemed to be in the same 
category or class. This test can thus be used in some situations to assess the 
reliability of a particular investigation. ICCs are ratios of rating variance to total 
variance. They compare the covariance of the ratings with total variance. For 
continuous parameters such as IOP, ICC is considered superior to the kappa 
statistic which is normally used to test agreement with dichotomous variables. 
We chose ICC as the most accurate and statistically acceptable test of agreement 
between the initial intraocular pressure recorded and the diurnal variation of 
tension. 
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Receiver Operator Characteristic Curve (ROC curve): It is a curve to establish a 
relationship between sensitivity and specificity.  
Sensitivity is defined as the proportion of people with the disease who have a 
positive test for the disease. A sensitive test will rarely miss people with the 
disease. 
Specificity:  is the proportion of people without the disease who have a negative 
test. A specific test will rarely misclassify people without the disease as diseased.  
Disease  Present Absent
Positive A b 
Te
st
 
Negative C d 
 
   
Consider the above table which is a 2x2 representation of data obtained while 
testing for a disease against a gold standard.  The lower case letters in the four 
cells represent numbers of patients who fall into the categories indicated.  From 
this table we calculate sensitivity as a/(a+c) and specificity as b/(b+d).                                                 
An ROC curve is constructed by plotting the true-positive rate 
(sensitivity) against the false positive rate (1-specificity) over a range of cut-off 
values. Tests that perform less well have curves that fall closer to the diagonal 
running from lower left to upper right. The diagonal shows the relation ship 
between true-positive and false-positive rates that would occur for a test yielding 
no information i.e. a test with a 50% chance of being positive. The value of a test 
lies in its predictive value, and this is dependent on the actual prevalence of the 
condition being tested for in the population being tested. The ROC curve helps in 
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this situation by allowing us to decide where the best cut off point should be (at 
or near the “shoulder” of the ROC curve). 
 
The over all accuracy of a test can be described as the area under the 
ROC curve; larger the area, better the test. A curve that perfectly discriminates 
between the two groups would give a curve coincided with left and top sides of 
the plot. A test that is completely useless would give a straight line from bottom 
left corner to right top corner. The ROC curve compares a particular test to the 
already set gold standard; in this study we had to study the usefulness of diurnal 
variation of intraocular pressure for diagnosing glaucoma (for which the gold 
standard is intraocular pressure and disc and field changes) in eyes with 
pseudoexfoliation.  
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Test of Proportion (Critical Ratio, z test): 
 This is a simple statistical test to determine whether the ratio of 
distribution of dichotomous variables in a study population is different from the 
distribution in the general population (more than can occur by chance). We use 
this test to detect any disproportion in the sex distribution of our patients and also 
to determine whether IOP measurements were significantly different in unilateral 
PEX compared to the normal eye. 
Student’s t-test (Paired t-test): 
 This test is sampling a distribution about its mean. The t test determines a 
probability that two populations are the same with respect to the variable tested. 
We used this test to determine the effect of cataract surgery on the intraocular 
pressure in eyes with pseudoexfoliation, by comparing the paired distribution of 
mean preoperative IOP and mean postoperative IOP for each operated eye. 
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RESULTS AND ANALYSIS 
             The total number of patients screened for the study was 140.  Of these, 
100 consented to abide by the protocol and were enrolled.  The main reason 
given for unwillingness to participate was lack of time to spare for DVT and 
follow up visits.   
SEX  DISTRIBUTION: 
There were 55 males and 45 females enrolled (Figure 1).  Using the one 
sample test of proportion the sex distribution was not found to be significantly 
different from the general population (p = 0.32). 
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Figure 1: Sex Distribution of Subjects 
 
DISTRIBUTION ACCORDING TO AGE: 
All patients included in this study were above 40 years of age. The mean 
age was 64.8 (±7.98SD), the minimum age being 45years and maximum age 
being 82 years. The maximum number of patients was in the age group of 60-69 
years (Table1; Figure 2). 
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Table 1: Age Distribution of Patients 
Age Group (Years) Number of Subjects
40-49 3 
50-59 19 
60-69 47 
70-79 26 
≥ 80 5 
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             Figure 2: Bar Chart Representation of Age Distribution 
  
Patients included this study were those who came to our institution over a 
period of 15 months. These were patients who visited or were referred to our 
outpatient department as well as patients presenting to our outreach cataract and 
ocular morbidity screening camps. As expected, the majority of patients willing 
to enroll in the study were from within Vellore District.  These numbered 81.  
The remaining patients were from towns and cities outside Vellore. 
UNILATERAL or BILATERAL: 
 
Patients in this study had either unilateral or bilateral presentation of 
pseudoexfoliation. Pseudoexfoliation material was noted on the corneal 
endothelium, on the pupillary margin, on the lens and in the angles. Early stages 
of pseudoexfoliation i.e. “brown stage” which consists of subtle changes to the 
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lens capsule predominantly marked by streaks of iris pigment on the zonules 
were also seen and included in the study.  
Forty-eight patients had unilateral PEX and fifty-two had bilateral PEX. 
Of patients who presented with unilateral pseudoexfoliation 28 had no difference 
in presenting intraocular pressure between the eyes that had pseudoexfoliation 
and the eye that did not have pseudoexfoliation. 18 patients showed a difference 
between the affected and unaffected eyes and 2 patient’s data were missing (see 
Table 2).  
Table 2: Difference in presenting IOP in unilateral PEX 
Number of Patients Initial IOP (mmHg)
28 0 
7 1 
6 2 
1 3 
1 4 
0 5 
1 6 
2 ≥7 
 
Using the two sample test of proportion, a p value of 0.037 was obtained, 
thus showing that there was no significant difference in presenting intraocular 
pressure between the eye having pseudoexfoliation and the eye not having 
pseudoexfoliation.     
INITIAL IOP and DVT 
 
The initial intraocular pressure recorded in patients with 
pseuodexfoliation was as shown (Table 3; Fig 3).  The maximum number of eyes 
was in the pressure range 10-14 mmHg. The data of 4 eyes were missing. 
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Table 3: Distribution of Presenting IOP    
 
0
20
40
60
80
100
N
um
be
r o
f e
ye
s
<10 10 to14 15-19 20-24 25-29 >30
Range of IOP (mmHg)
 
Figure 3: Distribution of Initial IOP Measurements 
 
According to our definition of secondary glaucoma, we defined five eyes 
as having PEX glaucoma.  Of these two underwent combined glaucoma and 
cataract surgery, as they either had IOP > 30 mmHg or showed advanced disc 
damage or both.  Two more eyes were started on medical therapy and underwent 
cataract surgery.  One patient is being followed up without surgery or medical 
treatment as she demonstrates no evidence of disc damage. 
            The details of the DVTs recorded are given below (Tables 4 and 5).  Only 
two eyes had a DVT greater than 6 mmHg.  These were eyes which had 
IOP Range 
(mmHg) 
Number of eyes 
<10 10 
10-14 93 
15-19 66 
20-24 21 
25-29 3 
≥30 3 
Missing 4 
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confirmed PEX glaucoma and underwent combined cataract and glaucoma 
surgery.  Interestingly, the remaining eyes which fulfilled the diagnostic criteria 
for secondary glaucoma did not demonstrate a wider than normal variation of 
IOP.  These were eyes which did not show much evidence of damage to the optic 
nerve head. 
            We further analyzed the IOP data with ICC and ROC curves (see later). 
Table 4: Variation in IOP measured by DVT (mmHg) 
 
       Number of eyes 
Variation in IOP
 RE LE 
0 14 22 
1 11 07 
2 48 40 
3 06 05 
4 12 12 
5 03 03 
6 01 04 
≥7 00 02 
missing 05 05 
  
Table 5: Mean and standard deviation of initial IOP and DVT 
  
                         Mean IOP (DVT) Age group Mean  IOP 
(Initial) 
RE LE 
40-49 18.33(±5.86) 17.83 (±4.53) 18.33 (±5.00) 
50-59 14.50(±3.52) 13.92 (±3.64) 14.25 (±3.57) 
60-69 15.94(±4.71) 15.25(±3.58) 16.33(±5.41) 
70-79 15.13 (±4.33) 14.77 (±3.57) 15.67 (±4.55) 
≥80 13.33 (±1.15) 11.62(±0.629) 12.18(±1.02) 
 
EFFECT OF CATARCT SURGERY : 
As we had 77 patients with cataract, the effect of cataract surgery on 
intraocular pressure was analyzed. Of the 77 undergoing cataract surgery 31 
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returned for the 6 week follow up visit. Using the paired t-test, we compared the 
preoperative and 6 week postoperative intraocular pressures (see Table 6). In this 
group, cataract surgery did not have any effect on the intraocular pressure in eyes 
with pseudoexfoliation. 
Table 6: Effect of cataract surgery on IOP 
  
                          
Mean IOP (± Standard Deviation) mmHg
Preoperative Postoperative 
15.19 ± 3.86 15.25 ± 4.06 
p = 0.149 
  
To assess the agreement between the initial intraocular pressure recorded 
and the diurnal variation of intraocular pressure, we used the intra class 
correlation coefficient (ICC). It was shown with this test that there was good 
agreement between the initial intraocular pressure recording and the diurnal 
variation of intraocular pressure. We analyzed the right and left eyes separately, 
and since both showed good agreement it was unnecessary to pool the data and 
do a further analysis.  In practical terms, what the test showed was that the DVTs 
performed were likely to be highly reliable, judging from the initial IOP. 
 Reliability - Intra Class Correlation Coefficient for DVT and IOP (right 
eyes) 
 
R E L I A B I L I T Y   A N A L Y S I S   -   S C A L E   (A L P H A) 
Intraclass Correlation Coefficient 
  
Two-way Random Effect Model (Absolute Agreement Definition): 
People and Measure Effect Random 
Single Measure Intraclass Correlation = 0.7359 
95.00% Confidence Interval:  Lower = 0.6277  Upper = 0.8162 ; P < = 0.0001   
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Figure 4: ICC curve for DVT and IOP (RE) 
 
 
Reliability - Intraclass correlation coefficient for IOP and DVT (left eyes) 
  
R E L I A B I L I T Y   A N A L Y S I S   -   S C A L E   (A L P H A) 
Intraclass Correlation Coefficient 
  
Two-way Random Effect Model (Absolute Agreement Definition): 
People and Measure Effect Random 
Single Measure Intraclass Correlation = 0.8100 
95.00% Confidence Interval:  Lower = 0.7272    Upper = 0.8695 
 P< 0.0001   
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                                                                     Figure 5: ICC curve for DVT and IOP (LE) 
  
   
To assess the need for doing diurnal variation of intraocular pressure in 
eyes with pseudoexfoliation, the data was analyzed using the receiver operator 
characteristic curve. This analysis showed that there was no benefit in recording 
a diurnal variation of intraocular pressure in eyes with pseudoexfoliation in order 
to detect pseudoexfoliation glaucoma.  The ROC curves for the right and left 
eyes are shown in Figures 6 &7. From the shape of the curves it is apparent that 
DVT is not of any use compared to initial IOP in diagnosing PEX glaucoma. 
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Figure 6:  ROC curve for Right Eye 
 
 
 
 
Figure 7: ROC curve for Left Eye 
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CUP-DISC RATIO: 
 
The cup-disc ratio was assessed stereoscopically using the slit-lamp 
biomicroscope and +90D lens. Due to the presence of cataract, a detailed disc 
examination was not possible in most patients, though an impression of cup-disc 
ratio was recorded. In 13 patients even this could not be assessed due to 
advanced cataract. (see Table 7; Figure 8) 
Table 7: Cup-Disc Ratio Distribution 
Cup-disc ratio Number of 
patients 
  0.2 9 
0.3 32 
0.4 22 
0.5 10 
0.6 8 
0.7 5 
0.8 1 
Hazy media 13 
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Figure 8 : Distribution of Cup-Disc Ratio  
  
Among the patients under study, only one patient had narrow angles not 
judged to be occludable and the remaining had open angles. There were none 
with closed angles, peripheral anterior synechiae or evidence of past closure.  
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Other features such as the presence and density of pigmentation, Sampaolesi’s 
lines, the distribution and density of PEX material deposition and other details 
were not required by the study protocol and hence not recorded.  
Visual fields assessed by Humphrey’s Field Analyzer II prior to cataract 
surgery were unreliable in all patients. Even though the visual acuity improved 
after cataract surgery, the repeat fields did not meet the reliability criteria. Hence 
analysis of visual field data could not be done. 
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DISCUSSION 
 
 
The awareness of the importance of pseudoexfoliation syndrome has 
increased considerably in recent years.[1] We have realized that it is a common 
disorder affecting a large proportion of our cataract and glaucoma patients, we 
have improved the diagnosis of early stages and we are beginning to understand 
the underlying pathophysiology. [6] Pseudoexfoliation syndrome is not only an 
ocular disease but a generalized disorder involving abnormal production or 
turnover of extra cellular matrix material or both. The PEX material itself has 
been shown to be an abnormal basement membrane like material in several 
intraocular and extraocular tissues.[8]  PEX syndrome is a common age-related 
though often overlooked disorder. The exact trigger for production of 
pseudoexfoliation material remains to be identified. [9] 
There are a number of ocular complications associated with 
pseudoexfoliation, most notably glaucoma.[9] Pseudoexfoliation glaucoma has 
sometimes been referred to as a rare secondary glaucoma, mainly seen in 
Scandinavian countries, but is now understood to be occurring worldwide. 
However, there may still be a need to increase the awareness of its importance. 
Previous studies have demonstrated that the prevalence of glaucoma is higher in 
patients with pseudoexfoliation than in those without pseudoexfoliation.[16] 
Pseudoexfoliation glaucoma is identified as the most common cause of 
secondary open angle glaucoma.[10] Though open angles are generally described 
with pseudoexfoliation, angle closure glaucoma may also occur due to the 
development of pupillary block secondary to posterior synechiae, increased iris 
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rigidity and decreased iris motility.  Impairment of the blood-aqueous barrier and 
increased protein concentrations in the aqueous humor with weak zonules result 
in forward movement of the lens-iris diaphragm. PEX may also occur in eyes 
with an anatomic predisposition to pupillary block such as eyes with short axial 
length and shallow anterior chamber depth.[9] 
Glaucoma associated with pseudoexfoliation is generally considered to 
result from obstruction of the aqueous outflow system either by pigment or by 
the exfoliative material, or both.[5] Ultra structural studies show that the 
progressive accumulation of pseudoexfoliation material in the trabecular 
meshwork causes a swelling of the juxtacanalicular tissue and a marked 
disorganization of the Schlemm’s canal architecture.  
Additional pathogenetic factors contributing to pressure rise and 
glaucoma development include marked pigment dispersion, increased aqueous 
humor protein concentrations, vascular factors and connective tissue alterations 
of the lamina cribosa.[9] 
Pseudoexfoliation glaucoma has a more serious clinical course and worse 
prognosis than primary open angle glaucoma.[9] It is typically associated with 
higher mean intraocular pressure levels, greater diurnal pressure fluctuations, 
marked pressure spikes, a higher frequency and severity of optic nerve damage, 
more rapid visual field loss, poorer response to medications, and more frequent 
necessity for surgical intervention.[6] Pseudoexfoliation glaucoma further differs 
from primary open angle glaucoma by demonstrating a more frequent asymmetry 
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of manifestation, more pronounced chamber angle pigmentation and acute rises 
in IOP after mydriasis.[9] 
There has been much speculation regarding why pseudoexfoliation is 
associated with a less favourable prognosis for glaucoma patients. To a certain 
extent the effect may be IOP mediated i.e., pseudoexfoliation may cause an 
increased IOP through production and deposition of pseudoexfoliation material 
and pigment in the trabecular meshwork and Schlemm’s canal with subsequent 
increased outflow resistance. However, because evidence that pseudoexfoliation 
seems to be an independent risk factor is increasing, it also seems reasonable to 
look for other possible explanations.[16] Elastosis affecting the lamina cribrosa 
might be a pathogenetic factor. An increased accumulation of elastic fibres in the 
lamina cribrosa in eyes with pseudoexfoliation glaucoma compared with eyes 
with POAG has been documented.[55] An effect on blood flow through vascular 
changes is another possibility. The presence of pseudoexfoliation fibres has been 
documented in the walls of ciliary arteries.  
In this study, we found a male: female ratio of 1.2:1 (p < 0.05) showing 
that there is no sex predilection for pseudoexfoliation. In a study done in south 
India by R Krishnadas et al where they have found a male preponderance in 
patients with pseudoexfoliation. On the contrary, Ritch et al found a female 
preponderance. Most of our patients were in the age group of 60-69years. Many 
patients in the older age group (i.e.≥70years) were not willing to undertake the 
study as they could not wait long hours in the hospital for diurnal variation of 
intraocular pressure recording; hence our age distribution is probably biased. Due 
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to the lack of data in this older age group, we are not able to demonstrate the 
already established fact that presence of pseudoexfoliation increases with 
age.[6,7,8] All stages of pseudoexfoliation were included in the study (i.e.) from 
the early ‘brown stage’ pseudoexfoliation to the established florid 
pseudoexfoliation. We lack data regarding the anatomical site of 
pseudoexfoliation material seen in the eye.  It would be interesting to look for an 
association between the site of pseudoexfoliation material seen and the presence 
of glaucoma.  For example, does the presence of pseudoexfoliation material and 
pigment in the angle increase the risk of a rise in intraocular pressure as 
suggested by the postulated mechanisms of pseudoexfoliation glaucoma? So, 
would recording of DVT after dilation be a better indicator of glaucoma in eyes 
with pseudoexfoliation? Longer follow up would be needed to see whether 
patients with early ‘brown’ stage pseudoexfoliation convert to florid 
pseudoexfoliation and PEX glaucoma. Does intraocular pressure have any 
correlation with the stage of pseudoexfoliation? 
Answering some of the above questions may also clarify some aspects of 
clinical practice.  Patients with open angle glaucoma based on IOP, disc and 
fields will be classified as PEX glaucoma if PEX is noted.  However, it is 
perfectly possible for a patient with POAG to have PEX.  The latter may not be 
contributing at all to the mechanism of glaucoma, but with our current 
understanding of the condition, we are not able to distinguish this possible subset 
from patients with true PEX glaucoma. 
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In this study we found no difference in intraocular pressure between the 
normal and affected eye in cases of unilateral pseudoexfoliation. Similar 
observation has been made by R Krishnadas et al[7] in a study from south India. 
Puska et al [10] in their study have found a difference in intraocular pressure 
between the pseudoexfoliation eye and fellow non-pseudoexfoliation eye. Can 
race have a role in determining the intraocular pressure in eye with 
pseudoexfoliation? A large, multicentric study would enable us to have a better 
insight into this finding. Remembering the fact that PEX was originally supposed 
to be peculiar to Scandinavian races, and the fact that there are still “pockets” 
around the world where PEX is common (eg in South India), racial differences in 
presentation, severity and prevalence of glaucoma in this condition need to be 
established.  Five of our 100 patients had PEX glaucoma, giving us a prevalence 
of 5% in our local population. 
We had 3 patients with unilateral PEX with IOP <22mHg but cup-disc 
ratio ≥0.7 in both eyes. Were these patients NTG or undiagnosed POAG with 
pseudoexfoliation a coincidental finding? To analyze this we would have to 
follow these patients for progression of cupping of the optic disc and for visual 
field defects. There were 2 patients in this study who had raised intraocular 
pressure but the optic disc cupping was 0.3. Are they really secondary 
(pseudoexfoliation) open angle glaucoma or are they ocular hypertensives with 
pseudoexfoliation being a coincidental finding? These patients would also have 
to be followed up long term with optic disc and visual field assessment. Another 
interesting aspect to look for in clinically unilateral cases of pseudoexfoliation 
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would be any clues that would suggest the presence of pseudoexfoliation in the 
unaffected fellow eye. As mentioned earlier, pseudoexfoliation increases with 
age.  Pigment dispersion after dilation, increased pigmentation of trabecular 
meshwork and pupillary sphincter atrophy are seen in old age and in eyes with 
pseudoexfoliation. Is there a difference in the amount of pigment dispersed and 
the pattern of trabecular meshwork pigmentation in eyes with pseudoexfoliation 
compared to the non-affected eye? Would these findings give us any hint about 
the presence of pseudoexfoliation in the clinically unaffected eye?  
There is data available which documents that pseudoexfoliation eyes can 
have narrow angles and narrow angle glaucoma opposed to the popular belief 
that PEX glaucoma is a secondary open angle glaucoma. R Ritch et al found 17 
out of 60 patients with closed angles. Is pupillary block the only mechanism for 
angle closure in these eyes? If there is pupillary block, will peripheral iridotomy 
help?  It would be interesting to look for association between the axial length, 
anterior chamber depth and angle structure in eyes with pseudoexfoliation. Is 
hyperopia or myopia more common in pseudoexfoliation with closed angles?  In 
our group of patients shallow chambers and narrow angles were not noted.  
Large intraocular pressure variation and /or intraocular pressure spikes 
are major risk factors for glaucoma. DVT recording helps us to detect these 
variations and spikes. This test can be done in a clinic setting or as a recording 
over 24 hours. Konastas et al[13] have reported that the peak level of intraocular 
pressure occurs more frequently outside office hours and so 24 hour recording of 
the intraocular pressure would give a better idea of diurnal variation. We 
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recorded DVT in a clinic setting. We found in our study that there was a good 
agreement between the initial recording of IOP and DVT. Thus DVT did not 
have any added benefit in identifying glaucoma in eyes with pseudoexfoliation. 
While we have not, in our study, encountered any case of PEX glaucoma 
with an initial “normal” IOP who subsequently demonstrated a high IOP on 
DVT, we cannot with absolute certainty say that PEX glaucoma will present 
inevitably with an initially high IOP.  For our sample size with a value of zero 
patients of PEX glaucoma with normal initial IOP, the confidence interval 
calculations would suggest that as many as 6% could have PEX glaucoma and 
normal initial IOP in a general population.  Of interest, though, is the fact that no 
patient with initially high IOP had any recording of IOP less than 21 mmHg 
during the DVT.  This tends to reinforce our assumption that PEX glaucoma 
must present with an initially high IOP. 
Of equal interest is what happens to patients with normal IOP, PEX, 
normal discs and visually insignificant cataract.  The literature seems to suggest 
that some proportion of them will go on to develop PEX glaucoma[10], but there 
is no clinical indication of which patients are at risk for this progression.  We are 
thus not in a position to suggest with any authority a follow up schedule for these 
patients.  A yearly follow up for patients at risk for POAG due to ocular 
hypertension, family history, myopia, large cups and other established risk 
factors is reasonable because POAG progresses slowly.  Is the same follow up 
schedule acceptable for patients with PEX and no glaucoma? More data is 
needed to answer this question. 
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Krupin et al [71] and Merkur et al [72] have shown that cataract surgery has 
the effect of lowering IOP in eyes with pseudoexfoliation, though the exact 
mechanism in not known. Does removal of the lens remove the source of the 
PEX material and thus interrupt the chain of events leading up to glaucoma? 
Could lens thickness have a role to play in raised intraocular pressure in eyes 
with pseudoexfoliation? Does cataract surgery only relieve the pupillary block or 
does it open up any other channels for drainage of aqueous? Cataract surgery 
causes disruption of blood-aqueous barrier, increases post-operative 
inflammation and damages the trabecular meshwork. It could thus exacerbate the 
severity of already existing PEX glaucoma or possible precipitate the 
development of glaucoma in an eye “on the brink”. In eyes with 
pseudoexfoliation, postoperative inflammation persists for longer time than in 
normal eyes.[70]  Does the intraocular pressure rise after such prolonged 
inflammation and does permanent trabecular damage ensue? In our study, though 
had limited number of patients coming for the final postoperative visit, we found 
that cataract surgery had no effect on intra ocular pressure in eyes with 
pseudoexfoliation. Longer follow up and larger studies will help us to better 
understand the effect of cataract surgery on intraocular pressure. 
In our study, visual field examination by the Humphrey’s Field Analyzer 
II 30-2 SITA standard program was not a reliable indicator of disc damage 
caused by raised intraocular pressure. The main reasons were related to 
unreliability of the patient’s performance during the field test. This led to bizarre 
field printouts that were difficult to interpret. As most patients had advanced 
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cataract, this is not surprising.  In fact, the best visual acuity in our entire patient 
group was 6/24, and many had only finger counting vision. 
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CONCLUSIONS 
 
 
1. Recording diurnal variation of intraocular pressure in eyes with 
pseudoexfoliation does not provide any additional benefit compared to 
the initial presenting IOP. 
 
2. Initial intraocular pressure recording is sufficient to diagnose glaucoma in 
eyes with pseudoexfoliation.  Disc changes may provide an additional 
indication of advanced glaucoma. 
 
3. Visual field recordings in patients with pseudoexfoliation presenting to an 
ophthalmology OPD were found to be unreliable due to the profound 
drop in visual acuity caused by cataract. 
 
4. Cataract surgery was not shown to have any effect on intraocular pressure 
in eyes with pseudoexfoliation. 
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APPENDIX I 
 
PROFORMA FOR RECORDING DVT IN EYES WITH PSEUDOEXFOLIATION                               
SERIAL NO: 
NAME: 
HOSP:NO: 
AGE: 
ADDRESS: 
PSEUDOEXFOLIATION:                         U/L                                              B/L 
PRESENTING IOP:                                    RE                                               LE 
DISC                                                              RE                                               LE 
GRADE OF CATARACT                           RE                                               LE 
FIELD                                                            RE                                               LE 
 
 DVT:                     RE 
                                
                             LE 
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APPENDIX III 
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PIGMENTATION IN THE ANGLE 
 
Age
0
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number of people
Age
IOP R
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IOP R
Name Age Sex glaucoma U/L orB/L IOP R IOP L meanIOP DISC-R DISC-L CAT-R CAT-L catsurR
1 DHANU 75 M B/L 20 20 20 0.3 0.3 NS2 NS2
2 Thangavel 74 M B/L 14 14 14 0.3 0.3 NS1+PSC NS1+PSC Y
3 Kasturi 62 F B/L 12 14 13 0.6 Tilted disc NS2-3 NS2-3 Y
4 Pappama 65 F U/L 16 16 16 0.3 0.4-0.5 NS3+PSC NS2+PSC
5 Chandra 56 F U/L 8 8 8 0.3 0.3 NS1+PSC NS1 Y
6 Arjunan 69 M U/L 10 42 26 0.6 0.7 NS2-3 TRIPLE
7 Edward 75 M B/L 10 10 10 0.6 0.6 NS1 NS1
8 Rajamma 60 F U/L 16 16 16 0.4 0.6 NS2 NS1 Y
9 Saraswathy 58 F U/L 10 10 10 0.3 0.3 NS2 NS2 Y
10 Ranganath 71 M B/L 13 14 13.5 0.3 0.3 NS1 NS1
11 Yesodai 52 F B/L 12 12 12 0.3 0.3 NS2+PSC NS2+PSC
12 Swaminath 70 M U/L 18 20 19 0.3 0.3 NS2+PSC PC IOL Y
13 Chinnappa 64 M B/L 19 19 19 0.2 0.2 NS1 NS1
14 Devaraj 80 M U/L 12 12 12 0.4 0.4 PC IOL NS2-3 Y
15 Balakrishna 77 M U/L 18 18 18 0.4 0.5 PC IOL NS4
16 Ruckmani 55 F U/L 18 18 18 HAZY VIEWNO VIEW NS4+PSC NS4+PSC Y
17 Arul 55 F U/L 16 18 17 0.4 0.5 CLEAR CLEAR
18 Meenakshi 67 F B/L 14 16 15 0.3 0.3 NS4+PSC NS2 Y
19 Mani 73 M U/L 12 12 12 0.4 Tilted disc NS2 Aphakia Y
20 Thanjamma 68 F B/L 8 8 8 0.3 0.3 NS2 NS1 Y
21 Murugan 62 M U/L 12 12 12 0.4 0.4 NS2+PSC PC IOL Y
22 Alamelu 60 F U/L 0.2 0.3 NS2 NS1
23 Solaiamma 70 F 1 U/L 22 22 22 0.7 0.5-0.6 NS2 NS2
24 Mumataz 48 F 1 B/L 26 24 25 0.3 0.3 NS1+PSC NS1+PSC
25 Latheef 73 M B/L 15 14 14.5 0.5 0.5 NS2+PSC NS2+PSC Y
26 Jayabalan 64 M B/L 16 19 17.5 HAZY VIEWHazy view NS1 NS3
27 Nagaiah 73 M B/L 14 14 14 0.6 0.6 NS2-3 NS2-3 Y
28 Kesavan 70 M U/L 14 14 14 0.3 NO VIEW PC IOL NS3-4
29 Unnamalai 69 F U/L 8 8 8 0.6 NO VIEW NS2 NS2+PSC Y
30 Rajeswari 60 F U/L 10 10 10 0.2-0.3 NO VIEW PC IOL AIMC Y
31 Ponnusamy 73 M U/L 8 9 8.5 0.3-0.4 NO VIEW PC IOL MC Y
32 Sivapoosh 65 F B/L 16 14 15 0.6 0.7 NS2+PSC NS2+PSC
33 Venugopa 49 M B/L 16 16 16 0.3 0.3 NS2+PSC NS1
34 Srinivasan 70 M B/L 10 11 10.5 0.3 0.3 NS1 NS1 Y
35 Gracy 56 F U/L 11 12 11.5 HAZY VIEW 0.4 NS2+PSC NS1+PSC Y
DVT=diurnal variation of intraocular pressure, R=right eye, L=left eye,IOP=intraocular pressure, DVT-F=follow up,U/L=unilateral,B/L=bilateral,r=reliable,nd=not 
done,ur=unreliable APPENDIX II
36 Radha 68 F B/L 15 15 15 No view 0.4 HMC NS2 Y
37 Babu 61 M U/L 20 20 20 0.2 0.2 NS1+PSC NS1+PSC Y
38 Ram 65 M U/L 17 16 16.5 0.3 0.4 NS1+PSC NS1+PSC
39 Kamalama 65 F B/L 22 15 18.5 0.5 0.6 NS1 NS2-3
40 Sowback 65 F B/L 18 18 18 No view 0.3 AIMC NS1+PSC Y
41 Vasantha 58 F B/L 18 13 15.5 0.3 0.3 NS1+PSC NS1+PSC Y
42 Jaya 60 F B/L 10 10 10 0.4 0.5 NS2 NS2
43 Kaniappan 55 M B/L 10 10 10 0.4 0.4 NS2 NS2
44 Raghu 45 M B/L 14 14 14 0.1 0.1 CLEAR CLEAR
45 Prabhavati 50 F U/L 13 13 13 0.3 0.3 NS2 NS2 Y
46 Jani Bhai 75 M U/L 11 10 10.5 0.3 0.3 PC IOL NS2-3
47 Palani 65 M B/L 18 24 21 0.4-0.5 0.5 NS2+PSC Early NS Y
48 Rangamma 60 F B/L 12 12 12 HAZY VIEWHazy view NS2-3 NS2-3 Y
49 Boopalan 55 M B/L 19 17 18 No view 0.4-0.5 AIMC NS2+PSC Y
50 Rose 82 F U/L 16 16 16 No view 0.4 AIMC Aphakia Y
51 Nallatham 53 M U/L 15 15 15 0.7 0.7 NS1+PSC NS1+PSC
52 Jayalaksmi 67 F B/L 12 14 13 0.3 0.3 NS1+PSC NS1+PSC
53 Srinivasulu 65 M U/L 18 16 17 0.6 0.6 NS2 PC IOL Y
54 Janakiama 70 F B/L 10 10 10 HAZY VIEWHazy view NS2-3 NS2-3 Y
55 Rajmurthi 52 M B/L 14 17 15.5 0.5 0.6 NS1+PSC NS1+PSC
56 Duraisamy 80 M U/L No view Hazy view AIMC Aphakia Y
57 Saraswathy 53 F U/L 19 19 19 0.4 0.4 Early NS Early NS
58 Dharmaling 69 M B/L 16 21 19 0.4 0.6 PC IOL NS2
59 Gouramma 50 F U/L 13 16 19 0.5 0.6 NS2 NS2 Y
60 Poongavan 65 F U/L 15 16 19 0.3 0.3 NS2+PSC NS2+PSC Y
61 Saminath 65 M B/L 14 14 19 0.5 0.5 NS2+PSC NS2+PSC Y
62 Girija 55 F B/L 18 15 19 No view 0.5 AIMC NS1 Y
63 Gangulapa 69 M B/L 7 8 19 HAZY VIEWHazy view MC NS2+PSC Y
64 Sulochana 63 F B/L 16 14 19 HAZY VIEW 0.5 NS2+PSC NS1 Y
65 Vardhan 63 M B/L 12 12 19 HAZY VIEWHazy view NS3+PSC NS3-4
66 Mani 63 M U/L 14 14 19 0.3 0.3 NS2+PSC NS2+PSC
67 Govindama 65 F U/L 14 14 19 0.7 0.8 NS3 NS3
68 Saroja 67 F B/L 18 16 19 0.4 0.4 NS2 NS1 Y
69 Duraisamy 60 M B/L 15 15 19 0.3 0.3 Early NS Early NS
70 Abdul 70 M B/L 14 14 19 O.3 0.3 NS2+PSC NS2+PSC Y
71 Subramani 65 M U/L 14 14 19 0.2 0.3 NS2-3 NS2-3 Y
DVT=diurnal variation of intraocular pressure, R=right eye, L=left eye,IOP=intraocular pressure, DVT-F=follow up,U/L=unilateral,B/L=bilateral,r=reliable,nd=not 
done,ur=unreliable APPENDIX II
72 Muthu 65 M 1 U/L 12 24 19 0.5 0.5 PC IOL NS1-2
73 Dorairaj 68 M B/L 22 22 22 0.7 0.7 NS2 NS2
74 Rajeswari 61 F B/L 21 21 19 0.3 0.3 CLEAR CLEAR
75 Lakshmi 80 F U/L 14 14 19 No view 0.3 NS4+PSC PC IOL Y
76 Krishnasam 80 M B/L 14 14 19 HAZY VIEW 0.4 NS4+PSC NS4+PSC Y
77 Neelamaga 58 M U/L 12 12 19 0.4 0.4 CLEAR CLEAR
78 Margatham 56 F B/L 21 21 19 0.3 0.3 NS1 NS2+PSC
79 Santa 54 F B/L 18 18 19 0.3 0.3 Early NS Early NS
80 Balaraman 57 M U/L 12 10 19 0.2 0.2 NS3+PSC PC IOL Y
81 Joseph 68 M U/L 18 20 19 0.4 0.4 PC IOL NS3-4
82 Muthamma 79 F U/L 14 16 19 HAZY VIEW 0.4 NS2+PSC NS2 Y
83 Mary 60 F U/L 15 16 19 0.4 0.3 NS2-3 NS2-3
84 Sakkubai 65 F U/L 12 12 19 0.3 0.3 NS2-3 PC IOL Y
85 Kuppan 71 M U/L 14 14 19 0.3 NO VIEW NS2-3+PSCMC
86 Sivalingam 67 M B/L 14 12 19 0.4 0.4 NS1-2+PSCNS1-2+PSCY
87 Damodaran 64 M B/L 14 14 19 0.3 Hazy view NS1 NS1+PSC
88 Thanjai 65 F B/L 13 11 19 0.3 0.3 NS2-3 NS2-3 Y
89 Yesodamm 70 F B/L 14 16 19 No view 0.2 MC NS2-3 Y
90 Sahu 75 M U/L 18 19 19 0.5 0.5 PC IOL MC
91 Andalama 60 F U/L 18 18 19 0.3 0.3 NS1 NS1
92 Jeeva 70 M B/L 22 21 19 0.3 0.3 NS1-2 NS1-2 Y
93 Guruviah 69 M B/L 14 14 19 0.5 0.5 NS2-3 NS1
94 Ramadoss 61 M B/L 14 14 19 0.4 0.4 NS3-4 NS3-4
95 Nesamani 62 M 1 B/L 28 32 19 HAZY VIEW 0.9 NS4+PSC NS2-3
96 Munisamy 69 M 1 U/L 24 30 19 HAZY VIEWHazy view NS2 NS3
97 Subramani 60 M U/L 16 16 19 0.6 0.6 PC IOL NS1-2+PSC
98 Sampatham 75 F U/L 14 12 19 0.2 NO VIEW PC IOL AIMC
99 Bhavani 70 F U/L 18 18 19 0.4 NO VIEW PC IOL AIMC
100 Govindamm 75 F B/L 12 12 19 0.3 0.4 NS2+PSC NS2-3+PSC
DVT=diurnal variation of intraocular pressure, R=right eye, L=left eye,IOP=intraocular pressure, DVT-F=follow up,U/L=unilateral,B/L=bilateral,r=reliable,nd=not 
done,ur=unreliable APPENDIX II
catsurL DVT-R1 DVT-R2 DVT-R3 DVT-R4 meandvtR DVT-L1 DVT-L2 DVT-L3 DVT-L4 meandvtL FIELD-R FIELD-L DVT-FR1
18 20 18 16 18 18 20 20 20 19.5 ur ur
Y 14 12 12 14 13 12 12 12 12 12 ur ur 10
18 21 23 22 21 18 20 21 21 20 ur ur 20
16 14 16 16 15.5 14 14 14 16 14.5 ur ur
8 10 8 8 8.5 10 10 10 10 10 ur ur 14
10 10 10 12 10.5 32 30 30 34 31.5 ur ur
Y 11 10 10 10 10.25 11 10 10 10 10.25 r r 10
16 14 16 16 15.5 16 14 14 14 14.5 ur ur 14
8 10 10 10 9.5 12 12 10 12 11.5 ur ur 10
14 15 14 14 14.25 14 15 14 14 14.25 ur ur
Y 12 12 12 12 12 12 10 10 12 11 r r 9
16 17 15 17 16.25 14 15 15 18 15.5 r r 24
16 14 16 12 14.5 18 14 12 12 14 ur ur
Y 10 12 10 12 11 10 14 14 16 13.5 ur ur 18
Y 14 12 14 14 13.5 20 22 26 26 23.5 ur ur 16
21 21 18 20 20 21 21 18 20 20 ur ur
16 18 18 18 17.5 16 16 16 16 16 ur ur
16 16 15 16 15.75 14 14 14 16 14.5 ur ur
12 12 12 12 12 14 12 14 12 13 ur ur
12 12 12 14 12.5 12 12 12 12 12 ur ur 8
13 12 12 12 12.25 13 14 16 16 14.75 r r 13
15 18 16 18 16.75 14 18 18 18 17 ur ur
Y 26 24 26 26 25.5 28 26 28 28 27.5 ur ur 20
22 24 24 22 23 24 24 24 24 24 ur ur
14 12 15 14 13.75 15 16 14 14 14.75 14
14 16 16 16 15.5 16 16 14 16 15.5 ur ur
14 12 14 14 13.5 16 16 16 17 16.25 20
Y 14 14 12 14 13.5 16 14 14 14 14.5 r ur 11
8 10 8 10 9 8 6 10 8 8 ur ur 12
14 14 12 14 13.5 12 14 14 14 13.5 ur ur 10
10 12 9 10 10.25 8 10 10 10 9.5 r ur 22
Y 18 18 18 18 18 20 18 18 18 18.5 r r
18 14 16 16 16 18 16 16 16 16.5 r r
14 16 14 16 15 14 14 14 16 14.5 ur ur 10
10 11 11 10 10.5 10 12 10 10 10.5 ur ur 14
DVT=diurnal variation of intraocular pressure, R=right eye, L=left eye,IOP=intraocular pressure, DVT-F=follow up,U/L=unilateral,B/L=bilateral,r=reliable,nd=not 
done,ur=unreliable APPENDIX II
16 14 14 16 15 16 14 16 14 15 ur ur
12 16 16 16 15 12 16 16 16 15 r r
Y 14 18 16 16 16 14 14 14 16 14.5 ur ur 14
11 12 10 12 11.25 14 14 16 14 14.5 ur ur 14
18 18 20 20 19 18 20 20 20 19.5 ur ur
Y 10 10 10 10 10 10 10 10 10 10 ur ur
14 16 14 14 14.5 14 16 14 14 14.5 r r
14 15 14 15 14.5 14 15 15 15 14.75 ur ur
Y 16 18 16 16 16.5 18 20 20 20 19.5 22
16 14 16 18 16 18 14 16 18 16.5 r r
14 14 12 12 13 12 14 12 12 12.5 ur ur
18 18 18 18 18 18 18 18 18 18 nd ur
12 16 16 14 14.5 16 16 16 16 16 ur ur
12 14 14 14 13.5 14 14 14 14 14 r r
12 12 12 12 12 14 12 12 14 13 ur r
16 16 16 16 16 16 16 16 16 16 nd ur
10 10 10 10 10 10 10 10 10 10 ur ur
12 10 10 10 10.5 12 10 10 10 10.5 ur ur
12 10 12 12 11.5 10 10 12 12 11 nd nd
14 16 16 16 15.5 12 16 16 16 15 ur ur
Y 16 20 18 18 18 18 20 20 20 19.5 ur ur
15 16 16 16 15.75 14 16 16 16 15.5 ur ur 14
14 14 16 14 14.5 14 15 16 14 14.75 ur ur
21 17 21 21 20 21 17 21 21 20 ur ur 14
18 16 17 17 17 18 17 17 17 17.25 ur ur
10 8 10 10 9.5 10 10 10 10 10 ur ur 15
15 10 15 15 13.75 15 10 14 15 13.5 r r
Y 14 14 16 14 14.5 12 14 16 16 14.5 ur ur
Y 13 13 13 13 13 13 13 12 13 12.75 r r
Y 13 14 14 14 13.75 13 14 13 13 13.25 ur ur
18 18 18 18 18 18 16 18 18 17.5 r r 16
19 18 13 15 16.25 20 19 13 13 16.25 r r
14 14 14 14 14 14 14 14 14 14 ur ur
18 21 20 20 19.75 16 21 20 21 19.5 ur ur
DVT=diurnal variation of intraocular pressure, R=right eye, L=left eye,IOP=intraocular pressure, DVT-F=follow up,U/L=unilateral,B/L=bilateral,r=reliable,nd=not 
done,ur=unreliable APPENDIX II
Y 10 12 12 10 11 18 26 25 25 23.5 r r
Y 18 17 21 18 18.5 17 21 21 18 19.25 ur ur
18 20 18 18 18.5 20 18 18 18 18.5 r r
14 12 12 12 12.5 14 11 12 12 12.25 ur r
10 12 12 12 11.5 12 12 12 12 12 ur ur
10 10 10 10 10 10 10 10 10 10 ur ur
Y 14 16 16 14 15 14 16 16 16 15.5 ur ur
10 12 10 10 10.5 12 12 12 12 12 r r
10 10 10 10 10 10 10 10 10 10 ur r/ng
Y 18 18 20 20 19 20 20 20 20 20 ur ur
14 14 12 14 13.5 14 13 14 14 13.75 nd nd
Y 12 12 10 10 11 12 12 12 12 12 nd nd
12 14 14 14 13.5 12 16 14 14 14 ur ur
Y 22 21 21 21 21.25 22 21 21 18 20.5 ur nd
15 13 11 11 12.5 15 12 11 13 12.75 ur ur
Y 14 14 14 14 14 14 12 12 14 13 r r
14 13 14 14 13.75 14 16 14 14 14.5 ur ur
12 14 14 14 13.5 14 14 14 14 14 ur ur
Y 16 18 20 18 18 18 17 18 19 18 ur nd 16
18 18 18 18 18 18 20 18 18 18.5 r r
21 21 16 18 19 21 18 16 18 18.25 ur r
14 14 14 12 13.5 14 14 14 14 14 ur ur
Y 16 14 16 18 16 18 14 16 18 16.5 ur ur
Y 26 28 28 28 27.5 30 32 32 36 32.5 ur ur 26
Y 18 21 21 21 20.25 30 36 34 34 33.5 ur ur
Y 16 17 16 16 16.25 20 20 18 18 19 ur ur 17
Y 14 14 12 14 13.5 14 14 14 14 14 ur nd
Y 16 14 14 14 14.5 16 14 16 14 15 r nd
Y 12 14 12 12 12.5 14 14 12 12 13 ur ur
DVT=diurnal variation of intraocular pressure, R=right eye, L=left eye,IOP=intraocular pressure, DVT-F=follow up,U/L=unilateral,B/L=bilateral,r=reliable,nd=not 
done,ur=unreliable APPENDIX II
DVT-FR2 DVT-FR3 DVT-FR4 meanFdvt DVT-FL1 DVT-FL2 DVT-FL3 DVT-FL4 meanFdvtL
12 12 12 11.5 12 10 12 12 11.5
18 18 18 18.5 20 19 18 18 18.75
#DIV/0! #DIV/0!
10 10 10 11 12 10 10 10 10.5
#DIV/0! #DIV/0!
10 10 10 10 12 12 10 10 11
14 16 16 15 12 16 16 16 15
10 10 12 10.5 10 10 10 10 10
#DIV/0! #DIV/0!
10 10 10 9.75 10 10 10 10 10
21 24 26 23.75 24 21 24 24 23.25
#DIV/0! #DIV/0!
20 20 20 19.5 18 20 18 20 19
16 16 16 16 16 16 16 16 16
#DIV/0! #DIV/0!
#DIV/0! #DIV/0!
#DIV/0! #DIV/0!
#DIV/0! #DIV/0!
10 10 10 9.5 10 10 10 10 10
13 12 13 12.75 12 12 13 12 12.25
#DIV/0! #DIV/0!
20 22 20 20.5 22 24 22 24 23
#DIV/0! #DIV/0!
14 14 14 14 14 14 12 14 13.5
#DIV/0! #DIV/0!
18 16 20 18.5 20 20 18 20 19.5
11 10 11 10.75 8 10 10 10 9.5
12 14 14 13 20 16 18 18 18
12 10 10 10.5 8 12 12 12 11
16 16 16 17.5 20 16 16 16 17
#DIV/0! #DIV/0!
#DIV/0! #DIV/0!
10 10 10 10 10 10 10 10 10
14 12 12 13 14 12 12 12 12.5
DVT=diurnal variation of intraocular pressure, R=right eye, L=left eye,IOP=intraocular pressure, DVT-F=follow up,U/L=unilateral,B/L=bilateral,r=reliable,nd=not 
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#DIV/0! #DIV/0!
#DIV/0! #DIV/0!
#DIV/0! #DIV/0!
15 15 14 14.5 14 14 14 13 13.75
14 14 14 14 16 14 14 14 14.5
#DIV/0! #DIV/0!
#DIV/0! #DIV/0!
#DIV/0! #DIV/0!
#DIV/0! #DIV/0!
#DIV/0! #DIV/0!
24 22 22 22.5 22 22 22 22 22
#DIV/0! #DIV/0!
#DIV/0! #DIV/0!
#DIV/0! #DIV/0!
#DIV/0! #DIV/0!
#DIV/0! #DIV/0!
#DIV/0! #DIV/0!
#DIV/0! #DIV/0!
#DIV/0! #DIV/0!
#DIV/0! #DIV/0!
#DIV/0! #DIV/0!
#DIV/0! #DIV/0!
#DIV/0! #DIV/0!
17 17 16 16 14 14 17 14 14.75
#DIV/0! #DIV/0!
16 16 16 15.5 14 14 16 14 14.5
#DIV/0! #DIV/0!
16 16 16 15.75 16 16 16 16 16
#DIV/0! #DIV/0!
#DIV/0! #DIV/0!
#DIV/0! #DIV/0!
#DIV/0! #DIV/0!
16 13 13 14.5 16 13 12 13 13.5
#DIV/0! #DIV/0!
#DIV/0! #DIV/0!
#DIV/0! #DIV/0!
DVT=diurnal variation of intraocular pressure, R=right eye, L=left eye,IOP=intraocular pressure, DVT-F=follow up,U/L=unilateral,B/L=bilateral,r=reliable,nd=not 
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#DIV/0! #DIV/0!
#DIV/0! #DIV/0!
#DIV/0! #DIV/0!
#DIV/0! #DIV/0!
#DIV/0! #DIV/0!
#DIV/0! #DIV/0!
#DIV/0! #DIV/0!
#DIV/0! #DIV/0!
#DIV/0! #DIV/0!
#DIV/0! #DIV/0!
#DIV/0! #DIV/0!
#DIV/0! #DIV/0!
#DIV/0! #DIV/0!
#DIV/0! #DIV/0!
#DIV/0! #DIV/0!
#DIV/0! #DIV/0!
#DIV/0! #DIV/0!
#DIV/0! #DIV/0!
16 16 16 16 16 18 18 18 17.5
#DIV/0! #DIV/0!
#DIV/0! #DIV/0!
#DIV/0! #DIV/0!
#DIV/0! #DIV/0!
25 28 28 26.75 15 18 15 15 15.75
#DIV/0! #DIV/0!
18 18 18 17.75 18 18 18 18 18
DVT=diurnal variation of intraocular pressure, R=right eye, L=left eye,IOP=intraocular pressure, DVT-F=follow up,U/L=unilateral,B/L=bilateral,r=reliable,nd=not 
done,ur=unreliable APPENDIX II
